FDA Approves Nasacort AQ For Children

The U.S. Food and Drug Administration (FDA) has approved Sanofi-aventis’ Nasacort AQ® Nasal Spray (triamcinolone acetonide) for children two to five years of age for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis (Medical News Today).

Leave a Reply

Your email address will not be published. Required fields are marked *